Etiology and diagnosis of acquired von Willebrand syndrome

Clinical Advances in Hematology and Oncology

Volumn 8, Issue 1, 2010, Pages 20-24

  Franchini, Massimo ^a   Lippi, Giuseppe ^a   Favaloro, Emmanuel J ^b  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CORTICOSTEROID; DESMOPRESSIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PLASMA SUBSTITUTE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THYROXINE; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

ANTIGEN BINDING; BLEEDING; BLOOD CLOT RETRACTION; BLOOD CLOTTING TIME; CONGENITAL DISORDER; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; DYSPLASIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; GENETIC ANALYSIS; HEART DISEASE; HUMAN; IMMUNOADSORPTION; IMMUNOPATHOLOGY; INFECTION; LYMPHOPROLIFERATIVE DISEASE; MONOCLONAL IMMUNOGLOBULINEMIA; MYELOMA; MYELOPROLIFERATIVE DISORDER; NEOPLASM; NOTE; PARTIAL THROMBOPLASTIN TIME; PLASMAPHERESIS; PROTHROMBIN TIME; RECEPTOR BINDING; SCREENING TEST; THROMBOCYTE COUNT; VON WILLEBRAND DISEASE; WALDENSTROEM MACROGLOBULINEMIA; ARTICLE; BLEEDING TIME; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TEST;

BLEEDING TIME; BLOOD COAGULATION; BLOOD COAGULATION TESTS; HUMANS; VON WILLEBRAND DISEASES;

EID: 76149105503     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (30)

1. Simone JV, Cornet JA, Abildgaard CF. Acquired von Willebrand's syndrome in systemic lupus erythematosus. Blood. 1968;31:806-812.
2. Franchini M, Lippi G. Acquired von Willebrand syndrome: an update. Am J Hematol. 2007;82:368-375.
3. Veyradier A, Jenkins CS, Fressinaud E, Meyer D. Acquired von Willebrand syndrome: from pathophysiology to management. Thromb Haemost. 2000;84: 175-182.
4. Franchini M, Lippi G. Recent acquisitions in acquired and congenital von Willebrand disorders. Clin Chim Acta. 2007;377:62-69.
5. Favaloro EJ. Laboratory identification of von Willebrand disease: technical and scientific perspectives. Semin Thromb Hemost. 2006;32:456-471.
6. Franchini M, Montagnana M, Manzato F, Vescovi PP. Thyroid dysfunction and hemostasis: an issue still unresolved. Semin Thromb Hemost. 2009;35:288-294.
7. Kershaw G, Jayakodi D, Dunkley S. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia centre. Semin Thromb Hemost. 2009;35:760-768.
8. Coleman R, Favaloro EJ, Soltani S, Keng TB. Acquired von Willebrand disease: potential contribution of the VWF:CB to the identification of functionally inhibiting auto-antibodies to von Willebrand factor. J Thromb Haemost. 2006;4:2085-2088.
9. Guerin V, Ryman A, Velez F. Acquired von Willebrand disease: potential contribution of the von Willebrand factor collagen-binding to the identification of functionally inhibiting auto-antibodies to von Willebrand factor: a rebuttal. J Thromb Haemost. 2008;6:1051-1052.
10. Favaloro EJ. Genetic testing for von Willebrand disease: the case against. J Thromb Haemost. 2009;8:6-12.
11. Favaloro EJ. Towards a new paradigm for the identification and functional characterisation of von Willebrand disease. Semin Thromb Hemost. 2009,35:60-75.
12. Tiede A, Priesack J, Werwitzke S, et al. Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study. J Thromb Haemost. 2008;6:569-576.
13. Michiels JJ, Budde U, van der Planken M, van Vliet H, Schroyens W, Berneman Z. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Best Pract Res Clin Haematol. 2001;14:401-436.
14. Tefferi A, Nichols WL. Acquired von Willebrand disease: Concise review of occurrence, diagnosis, pathogenesis and treatment. Am J Med. 1997;103:536-540.
15. Collins P, Budde U, Rand JH, Federici AB, Kessler CM. Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome. Haemophilia. 2008;14(suppl 3):49-55.
16. Mannucci PM, Lombardi R, Bader R. Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gamopathies. Blood. 1984;64:614-621.
17. Federici AB, Stabile F, Castaman G, et al. Treatment of acquired von Willebrand disease in patients with monoclonal gammopathy of uncertain significance: Comparison of three different therapeutic approaches. Blood. 1998;92:2707-2711.
18. Federici AB. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome. Hum Immunol. 2005;66:422-430.
19. Hayashi T, Yagi H, Suzuki H, et al. Low-dosage intravenous immunoglobulin in the management of a patient with acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance. Pathophysiol Haemost Thromb. 2002;32:33-39.
20. Michiels JJ, van Vliet HH. Willebrand disease in monoclonal gammopathies: Effectiveness of high-dose intravenous immunoglobulin. Clin Appl Thromb Hemost. 1999;5:152-157.
21. Arkel YS, Lynch J, Kamiyama M. Treatment of acquired von Willebrand syndrome with intravenous immunoglobulin. Thromb Haemost. 1994;72:643-644.
22. Frank RD, Kunz D, Wirtz DC. Acquired von Willebrand disease - hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion. Am J Hematol. 2002;70:64-71.
23. Eikenboom J, Brvan der Meer FJ, Briët E. Acquired von Willebrand's disease due to excessive fibrinolysis. Br J Haematol. 1992;81:618-620.
24. Friederich PW, Wever PC, Briet E, Doorenbos CJ, Levi M. Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease. Am J Hematol. 2001;66:292-294.
25. Smaradottir A, Bona R. A case of acquired von Willebrand syndrome successfully treated with recombinant factor VIIa during thyroidectomy. Thromb Haemost. 2005;93:1009.
26. Federici AB, Rand JH, Bucciarelli P, et al.; Subcommittee on von Willebrand Factor. Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost. 2000;84:345-349.
27. Scott JP, Montgomery RR, Tubergen DG, Hays T. Acquired von Willebrand's disease in association with Wilm's tumor: regression after treatment. Blood. 1987;58:247-257.
28. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349:343-349.
29. Joist JH, Cowan F, Zimmerman TS. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder. N Engl J Med. 1978;298:988-991.
30. Dalton RG, Savidge GF, Matthews KB, et al. Hypothyroidism as a cause of acquired von Willebrand's disease. Lancet. 1987;1:1007-1009.